Xiaoli Ma

4.2k total citations · 1 hit paper
139 papers, 3.0k citations indexed

About

Xiaoli Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaoli Ma has authored 139 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 29 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Xiaoli Ma's work include RNA modifications and cancer (16 papers), Nicotinic Acetylcholine Receptors Study (16 papers) and Cancer, Stress, Anesthesia, and Immune Response (12 papers). Xiaoli Ma is often cited by papers focused on RNA modifications and cancer (16 papers), Nicotinic Acetylcholine Receptors Study (16 papers) and Cancer, Stress, Anesthesia, and Immune Response (12 papers). Xiaoli Ma collaborates with scholars based in China, United States and Australia. Xiaoli Ma's co-authors include Hao Hu, Yanfei Jia, Ying Sun, Haiji Sun, Yang Liu, Airong Qian, Peihong Su, Ye Tian, Dongjie Xiao and Yunshan Wang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xiaoli Ma

128 papers receiving 2.9k citations

Hit Papers

The Influence of Cell Cycle Regulation on Chemotherapy 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Ma China 30 1.7k 521 515 320 256 139 3.0k
Tao Yu China 28 1.3k 0.8× 587 1.1× 546 1.1× 342 1.1× 216 0.8× 114 3.0k
Xin Xu China 35 1.8k 1.0× 464 0.9× 601 1.2× 268 0.8× 359 1.4× 142 3.5k
Fengjing Guo China 32 2.0k 1.2× 396 0.8× 1.0k 2.0× 478 1.5× 258 1.0× 111 3.7k
Liqun Chen China 28 1.4k 0.8× 488 0.9× 544 1.1× 187 0.6× 175 0.7× 69 2.7k
Xiaoyue Tan China 29 1.4k 0.8× 403 0.8× 482 0.9× 471 1.5× 206 0.8× 82 3.0k
Yiping Li China 30 2.6k 1.5× 571 1.1× 550 1.1× 262 0.8× 281 1.1× 107 4.3k
Chenping Zhang China 31 1.3k 0.8× 624 1.2× 589 1.1× 389 1.2× 543 2.1× 150 3.5k
Yun Yang China 26 1.5k 0.9× 850 1.6× 832 1.6× 258 0.8× 318 1.2× 86 2.7k
Huiling Liu China 29 1.7k 1.0× 283 0.5× 885 1.7× 406 1.3× 246 1.0× 87 3.0k
Peng Yang China 34 1.6k 0.9× 747 1.4× 381 0.7× 457 1.4× 387 1.5× 184 4.1k

Countries citing papers authored by Xiaoli Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).

Fields of papers citing papers by Xiaoli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.

Co-authorship network of co-authors of Xiaoli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Ma. A scholar is included among the top collaborators of Xiaoli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Ma. Xiaoli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Xiaoli, et al.. (2025). Sanguinarine Inhibits Gastric Cancer Progression by Targeting the NOS2/SOD1 Axis to Promote Ferroptosis. The American Journal of Chinese Medicine. 53(5). 1545–1571.
2.
Wang, Zepeng, Xinyu Li, Yuanyuan Li, et al.. (2025). The insular cortex-nucleus tractus solitarius glutamatergic pathway involved in acute stress-induced gastric mucosal damage in rats. Neurobiology of Stress. 36. 100723–100723.
3.
Bao, Shideng, et al.. (2025). Helicobacter pylori infection induces STAT3/MYBL2/NF-κB axis to promote gastric cancer progression. Tissue and Cell. 96. 103016–103016.
4.
Sun, Jingguo, et al.. (2024). Positive GLI1/INHBA feedback loop drives tumor progression in gastric cancer. Cancer Science. 115(7). 2301–2317. 5 indexed citations
5.
Meng, Xianguang, et al.. (2024). α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation. Archives of Dermatological Research. 316(6). 269–269. 2 indexed citations
6.
7.
Jiao, Yang, Pan Pan, Qiang Li, et al.. (2023). Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via α5-nAChR/FHIT pathway. Cellular and Molecular Life Sciences. 80(5). 119–119. 15 indexed citations
8.
Li, Qiang, Jingting Wang, Jing Wang, et al.. (2023). PLEK2 mediates metastasis and invasion via α5‐nAChR activation in nicotine‐induced lung adenocarcinoma. Molecular Carcinogenesis. 63(2). 253–265. 4 indexed citations
9.
Huang, Yijie, et al.. (2023). Mechanical Properties of Seawater Sea-sand Recycled Concrete in Sulfate Attack Environment. Journal of Physics Conference Series. 2535(1). 12015–12015. 1 indexed citations
10.
Liu, Duanrui, Yunyun Liu, Yi Lu, et al.. (2023). Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo–YAP1 pathway. BMC Medicine. 21(1). 134–134. 28 indexed citations
11.
Liu, Duanrui, Zongming Wang, Liping Sun, et al.. (2022). Comprehensive Analysis of N6-Methyladenosine (m6A) RNA Methylation Regulators and Tumour Microenvironment Cell Infiltration Involving Prognosis and Immunotherapy in Gastroesophageal Adenocarcinomas. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–17. 6 indexed citations
12.
Jia, Yanfei, Yanyan Liu, Jingyu Zhu, et al.. (2022). DEC1 promotes progression of Helicobacter pylori‐positive gastric cancer by regulating Akt/NF‐κB pathway. Journal of Cellular and Molecular Medicine. 26(7). 1943–1954. 10 indexed citations
13.
Zhu, Ping, et al.. (2022). The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion. Human Cell. 35(4). 1207–1218. 13 indexed citations
14.
Xiong, Jiantuan, Ning Ding, Tingting Gao, et al.. (2018). Hypermethylation of endoplasmic reticulum disulfide oxidase 1α leads to trophoblast cell apoptosis through endoplasmic reticulum stress in preeclampsia. Journal of Cellular Biochemistry. 119(10). 8588–8599. 13 indexed citations
15.
Huang, Kai, Jiarong Chen, Ru Xu, et al.. (2018). Molecular evolution of hepatitis C virus in China: A nationwide study. Virology. 516. 210–218. 15 indexed citations
16.
Ma, Xiaoli, Gwénaël Le Teuff, Benjamin Lacas, et al.. (2016). Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Journal of Thoracic Oncology. 11(6). 850–861. 77 indexed citations
17.
Ma, Xiaoli, Vanessa Rousseau, Haiji Sun, et al.. (2014). Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer. Molecular Oncology. 8(3). 555–564. 35 indexed citations
18.
Jia, Yanfei, Dongjie Xiao, Xiaoli Ma, et al.. (2013). Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer. Diagnostic Pathology. 8(1). 37–37. 40 indexed citations
19.
Ma, Xiaoli, Quanfu Ma, Jia Liu, et al.. (2009). Identification of LIV1 , a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach. Molecular Cancer Therapeutics. 8(11). 3108–3116. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026